Yes, Atrial Fibrillation Commonly Causes Fatigue
Fatigue is a well-recognized and frequent symptom of atrial fibrillation, affecting a substantial proportion of patients and significantly impacting their quality of life. 1
How AF Causes Fatigue
Atrial fibrillation produces fatigue through multiple physiological mechanisms:
- Reduced cardiac output: The loss of coordinated atrial contraction decreases ventricular filling by approximately 20-30%, reducing overall cardiac efficiency
- Irregular ventricular response: The chaotic heart rhythm prevents optimal cardiac performance during daily activities
- Tachycardia-related exhaustion: Uncontrolled rapid ventricular rates increase myocardial oxygen demand while reducing exercise tolerance
Evidence Supporting AF-Related Fatigue
The most recent research demonstrates that fatigue ranks among the seven most common symptoms in AF patients, alongside chest palpitations, dizziness, lack of energy, pulse skipping, insomnia, and heavy breathing 2. Importantly, fatigue can be the primary presenting symptom in some patients, even preceding other classic AF manifestations 3.
A 2024 study identified specific biomarkers associated with AF-related fatigue 4:
- NT-proBNP levels (cardiac overload marker) showed significant association with fatigue severity
- High-sensitivity troponin (myocardial injury marker) correlated with increased fatigue
- These findings suggest cardiac overload and myocardial injury—rather than inflammation—drive AF-related fatigue
Clinical Implications
Symptom burden directly correlates with psychological distress and reduced quality of life 2. The 2024 ESC guidelines explicitly recognize that rate control therapy is recommended specifically "to control heart rate and reduce symptoms" in AF patients 5, acknowledging fatigue as a treatable manifestation.
Management Approach
When fatigue is present:
Assess ventricular rate control: Target resting heart rate <110 bpm initially (lenient control), with stricter control (<80 bpm) reserved for persistent symptoms 5
First-line rate control agents 5:
- Beta-blockers, diltiazem, or verapamil (if LVEF >40%)
- Beta-blockers and/or digoxin (if LVEF ≤40%)
Consider rhythm control: Early rhythm control with catheter ablation is recommended for symptomatic patients to improve quality of life and reduce symptom burden 1
Evaluate for cardiac dysfunction: Check NT-proBNP and troponin levels if fatigue is severe, as elevated levels indicate cardiac overload or injury requiring more aggressive management 4
Common Pitfalls
- Don't dismiss fatigue as non-cardiac: Approximately 10-40% of AF patients may be asymptomatic regarding palpitations but still experience significant fatigue 1
- Don't accept inadequate rate control: If fatigue persists with lenient rate control, stricter targets are warranted 5
- Don't overlook depression: Fatigue correlates with depressive symptoms in AF patients, requiring concurrent assessment 4, 2